How Healthcare M&A Due Diligence Differs From Other Industries

 Mergers and acquisitions require careful due diligence in almost every industry. Buyers generally examine a target's financial position, contracts, assets, liabilities, employees, litigation and regulatory compliance before completing a transaction. Healthcare M&A requires a wider examination.

A healthcare business may operate hospitals, clinics, laboratories, pharmacies, diagnostic centres or digital health platforms. Its operations can involve patients, medical professionals, licences, clinical records, medicines, medical devices and highly sensitive personal information. This creates risks which may not arise in the same form in a conventional commercial transaction.

The Indian healthcare sector also has a complex regulatory environment. The India Code database lists legislation covering areas such as clinical establishments, medical professionals, pharmaceuticals, mental healthcare and allied healthcare professions.

As a result, healthcare M&A due diligence needs to examine not only whether a business is financially sound, but also whether it can continue operating lawfully after the transaction.

Why Healthcare Due Diligence Is Different

In a conventional acquisition, the buyer may focus primarily on financial performance, commercial contracts, intellectual property and corporate liabilities. Healthcare transactions require these checks as well, but the analysis often extends into clinical and regulatory operations.

A hospital, for example, is not simply an organisation selling a service. It operates within a regulated environment involving medical professionals, patient care, clinical standards, medicines, equipment and health records. A problem in any of these areas can affect the value and continuity of the business. This makes healthcare due diligence more operationally intensive than many other M&A transactions.

Regulatory Licences Need Detailed Review

Licensing is one of the first areas buyers need to examine. Healthcare businesses can require different registrations, permissions and approvals depending on their activities and location. A target may operate several facilities, with each location potentially subject to different requirements.

The buyer should therefore establish which licences are required, which entity holds them and whether they remain valid. It is also important to consider whether a proposed change in ownership or control affects any approval or registration. A transaction may otherwise appear commercially straightforward while the target's ability to continue operating remains dependent on regulatory compliance.

Clinical Establishment Compliance

Hospitals and other healthcare facilities can be subject to specific rules concerning their establishment and operation. The Clinical Establishments (Registration and Regulation) Act, 2010 is part of India's healthcare regulatory framework, although the applicability of particular legislation can depend on the relevant jurisdiction and circumstances.

Due diligence should therefore examine registration status, applicable standards and records maintained by the target.The review may also need to consider whether individual facilities are compliant with applicable local requirements. This is different from many sectors where regulatory review may focus mainly on corporate filings or industry licences.

Medical Professional Credentials Matter

Healthcare businesses depend heavily on doctors, nurses, technicians, pharmacists and other professionals. Their qualifications, registrations and contractual arrangements can therefore become an important part of due diligence. The National Medical Commission Act, 2019 forms part of India's statutory framework concerning medical education and the medical profession.

A buyer may need to verify whether relevant professionals hold the required registrations and whether their engagement arrangements are properly documented. The review may also examine employment agreements, consultant arrangements, professional indemnity coverage and disciplinary matters where relevant.

Patient Data Creates Additional Risk

Healthcare businesses process information of a particularly sensitive nature. Patient records can include medical histories, diagnostic reports, prescriptions, contact details and other personal information. The buyer therefore needs to understand how patient information is collected, stored, accessed and transferred.

India's Digital Personal Data Protection framework adds another important layer to data governance. The Ministry of Electronics and Information Technology has also published the Digital Personal Data Protection Rules, 2025 and an enforcement timeline. A healthcare transaction may require careful consideration of data processing arrangements, security practices and the legal basis for handling personal data.

Clinical Records Require Special Attention

Patient records are not ordinary business documents. Their integrity can affect patient care, regulatory compliance and potential liability. Due diligence may therefore examine how records are maintained, whether electronic systems are secure and whether access controls are properly implemented.

The buyer should also understand how records will be handled after completion. For example, if the transaction involves a transfer of business operations, the parties may need to determine how patient information can lawfully continue to be accessed and managed.

Medical Malpractice and Patient Claims

Healthcare businesses face litigation risks which may be different from those encountered by ordinary commercial enterprises. Claims can arise from alleged medical negligence, treatment outcomes, informed consent issues, contractual disputes or other patient related matters.

A buyer should therefore examine pending claims as well as historical complaints and settlements. The review should not focus only on the number of cases. The nature of the allegations, potential financial exposure and insurance arrangements can also be relevant. Past claims may reveal recurring operational issues which require attention after completion.

Pharmaceutical and Medical Device Compliance

Healthcare transactions involving hospitals, pharmacies, laboratories or manufacturers may require detailed review of medicines and medical devices. India has a statutory framework covering pharmaceuticals and related matters, including the Drugs and Cosmetics Act, 1940. Due diligence may therefore need to examine licences, procurement arrangements, storage procedures, quality controls and records relating to regulated products.

Medical devices can create additional considerations depending on their classification and use. A buyer should understand whether the target's operations comply with the rules applicable to the products and services it provides.

Healthcare Contracts Can Be More Complex

Healthcare businesses often have extensive contractual relationships. These can include agreements with doctors, insurers, suppliers, pharmaceutical companies, laboratories, equipment providers and technology vendors. Hospitals may also have arrangements with corporate customers, health insurance providers and third party administrators.

The buyer needs to understand whether these contracts can continue after the transaction. Change of control provisions are particularly important. Some agreements may require consent or notification before ownership changes.

Competition Law Can Be Important

Healthcare consolidation can raise competition issues, particularly where the parties have overlapping operations in the same geographic or service markets. The Competition Commission of India regulates combinations involving mergers, acquisitions and changes in control where the statutory requirements are met.

Recent healthcare transactions demonstrate the practical importance of competition review. In 2025, the CCI approved transactions involving Aster DM Healthcare and Quality Care India, as well as an acquisition involving HealthCare Global Enterprises.

The Commission's analysis can consider horizontal overlaps, vertical relationships and complementary activities. Healthcare buyers therefore need to assess competition implications early rather than treating them as a final stage issue.

Property and Facility Due Diligence

Healthcare businesses often depend on physical infrastructure. Hospitals, clinics and laboratories require suitable premises and specialised facilities. Due diligence should therefore examine property ownership or leases, approvals, construction permissions and use restrictions.

A buyer should also understand whether important equipment and infrastructure belong to the target or are leased from another entity. Property related problems can affect the ability to continue operating a facility after completion.

Employees and Consultant Arrangements

Healthcare organisations can have large workforces. Their employment structures may include permanent employees, consultants, visiting doctors and outsourced personnel. Due diligence should examine employment agreements, compensation arrangements, benefits, disputes and statutory compliance.

Consultant arrangements may require additional attention because healthcare professionals can have different contractual relationships with hospitals and clinics. The buyer should understand which personnel are essential to continued operations and whether their arrangements will remain effective after the transaction.

Intellectual Property and Health Technology

Healthcare M&A increasingly involves technology. Hospitals may use proprietary software, diagnostic systems, telemedicine platforms and patient management systems. Health technology businesses may have patents, software and databases as core assets.

The buyer should verify ownership and licensing arrangements. Third party technology agreements can also contain restrictions on assignment or change of control. A healthcare transaction involving substantial technology assets therefore requires both traditional intellectual property review and technology specific diligence.

Insurance and Indemnity Arrangements

Healthcare businesses can face substantial operational and professional risks. Insurance policies may cover medical malpractice, professional liability, property damage, cyber incidents and other exposures. The buyer should examine the scope of coverage, policy limits, exclusions and claims history.

It should also determine whether existing policies remain effective after completion or whether new arrangements will be required. Insurance can be particularly relevant where historical patient claims may emerge after the transaction.

Regulatory Investigations and Litigation

Healthcare targets should be reviewed for current and historical regulatory proceedings. These may involve licensing authorities, professional regulators, competition authorities, consumer disputes or other government bodies. The buyer should understand not only formal litigation but also significant notices, inspections and unresolved regulatory correspondence.

A target with repeated regulatory concerns may require more extensive investigation before completion. In complex transactions, specialist life sciences law firms can assist with understanding sector specific regulatory issues, particularly where the target operates across healthcare, pharmaceuticals, medical devices or biotechnology.

Why Healthcare Due Diligence Takes Longer

Healthcare diligence can take longer because several areas need to be reviewed simultaneously. Legal advisers may need to examine corporate records and contracts. Regulatory specialists may review licences and approvals. Data specialists may assess patient information systems. Financial teams may analyse reimbursement and revenue arrangements.

The different streams of diligence are also interconnected. For example, a regulatory issue may affect the value of a licence. A contractual restriction may affect a key healthcare partnership. A data issue may create regulatory and litigation exposure. The buyer therefore needs a coordinated diligence process.

What Happens When Due Diligence Identifies a Problem?

Not every issue discovered during healthcare diligence will prevent a transaction. The response depends on the nature and seriousness of the issue. The parties may negotiate a price adjustment, specific contractual protection, an indemnity or a requirement to remedy the issue before completion. Some problems may also require regulatory approval or restructuring. The important point is to identify material issues early enough for the parties to make informed decisions.

Post Acquisition Integration Matters

Healthcare diligence should not end when the transaction closes. The buyer may need to integrate policies, data systems, employment arrangements and compliance procedures. Patient care should continue without unnecessary disruption. Regulatory registrations and licences also need to remain properly managed. A well planned integration process can help ensure the target remains compliant after the change in ownership.

Healthcare M&A Disputes

Healthcare transactions can generate disputes over representations, warranties, undisclosed liabilities and regulatory compliance. A buyer may allege the seller failed to disclose a significant patient claim, regulatory issue or contractual restriction. The interpretation of warranties and indemnities can then become important.

Where an M&A dispute develops, specialist litigation lawyers for M&A disputes may need to examine the transaction documents, due diligence materials and evidence surrounding the disputed issue.

Conclusion

Healthcare M&A due diligence differs from diligence in many other industries because the target operates within a highly regulated and operationally sensitive environment. Buyers need to examine corporate and financial matters alongside healthcare licences, clinical operations, medical professionals, patient data, medicines, equipment, contracts, property and regulatory proceedings.

Competition law can also become important where healthcare businesses have overlapping activities. Recent CCI decisions involving healthcare transactions demonstrate how sector consolidation can require detailed competition analysis.

The central objective is not simply to identify legal problems. It is to understand how those issues could affect the target's ability to operate after the transaction. For this reason, healthcare M&A requires a coordinated approach involving corporate, regulatory, data, employment, intellectual property and litigation considerations. Thorough diligence can give both parties a clearer understanding of the business and help identify issues before they become post transaction disputes.